Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/25543
Appears in Collections:Aquaculture Journal Articles
Peer Review Status: Refereed
Title: Impact of Salmonid alphavirus infection in diploid and triploid Atlantic salmon (Salmo salar L.) fry (Forthcoming)
Authors: Herath, Tharangani
Ashby, Angela J
Jayasuriya, Nilantha Sandaruwan
Bron, James
Taylor, John
Adams, Alexandra
Richards, Randolph
Weidmann, Manfred
Ferguson, Hugh
Taggart, John
Migaud, Herve
Fordyce, Mark J
Thompson, Kim D
Contact Email: m.w.weidmann@stir.ac.uk
Keywords: Salmon
salmonid alphavirus
triploids
diploids
fry
Citation: Herath T, Ashby AJ, Jayasuriya NS, Bron J, Taylor J, Adams A, Richards R, Weidmann M, Ferguson H, Taggart J, Migaud H, Fordyce MJ & Thompson KD (2017) Impact of Salmonid alphavirus infection in diploid and triploid Atlantic salmon (Salmo salar L.) fry (Forthcoming), PLoS ONE.
Abstract: With increasing interest in the use of triploid salmon in commercial aquaculture, gaining an understanding of how economically important pathogens affect triploid stocks is important. To compare the susceptibility of diploid and triploid Atlantic salmon (Salmo salar L.) to viral pathogens, fry were experimentally infected with Salmonid alphavirus sub-type 1 (SAV1), the aetiological agent of pancreas disease (PD) affecting Atlantic salmon aquaculture in Europe. Three groups of fry were exposed to the virus via different routes of infection: intraperitoneal injection (IP), bath immersion, or cohabitation (co-hab) and untreated fry were used as a control group. Mortalities commenced in the co-hab challenged diploid and triploid fish from 11 days post infection (dpi), and the experiment was terminated at 17 dpi. Both diploid and triploid IP challenged groups had similar levels of cumulative mortality at the end of the experimental period (41.1 % and 38.9 % respectively), and these were significantly higher (p < 0.01) than for the other challenge routes. A TaqMan-based quantitative PCR was used to assess SAV load in the heart, a main target organ of the virus, and also liver, which does not normally display any pathological changes during clinical infections, but exhibited severe degenerative lesions in the present study. The median viral RNA copy number was higher in diploid fish compared to triploid fish in both the heart and the liver of all three challenged groups. However, a significant statistical difference (p < 0.05) was only apparent in the liver of the co-hab groups. Diploid fry also displayed significantly higher levels of pancreatic and myocardial degeneration than triploids. This study showed that both diploid and triploid fry are susceptible to experimental SAV1 infection. The lower virus load seen in the triploids compared to the diploids may possibly be related to differences in cell metabolism between the two groups, however, further investigation is necessary to confirm this and also to assess the outcome of PD outbreaks in other developmental stages of the fish when maintained in commercial production systems.
Rights: This item has been embargoed for a period. During the embargo please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study.

Files in This Item:
File Description SizeFormat 
PONE-D-16-33451R1_FTC.pdf543.86 kBAdobe PDFUnder Embargo until 10/10/2017     Request a copy

Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependent on the depositor still being contactable at their original email address.



This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.